Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153165 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-02-10 | 2022-07-01 | 154720 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-04-28 | 2022-07-01 | 159590 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-04-27 | 2023-06-27 | 190674 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195618 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-07-11 | 2025-10-16 | 198292 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-10-19 | 2024-06-13 | 207512 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2025-01-09 | 2025-10-16 | 247336 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-04 | 2019-06-03 | 68616 |
| TEVA-IRBESARTAN | 300MG | TABLET | Resolved | 2019-07-02 | 2021-09-10 | 88171 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2019-08-22 | 2021-05-06 | 92171 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2019-09-19 | 2021-09-10 | 94369 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-08 | 2023-11-03 | 194135 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-08 | 2024-04-11 | 194138 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195588 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195609 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2023-10-05 | 2023-11-03 | 206422 |
| TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2024-01-25 | 2024-04-01 | 217234 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |